Jonathan S. Lau

Array ( [id] => 20707899 [patent_doc_number] => 20260132227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-14 [patent_title] => COMPOSITIONS COMPRISING REACTION PRODUCTS OF SACCHARIDE POLYMERS AND FATTY ACIDS OR FATTY ESTERS FORMULATED WITH AN AMIDE-BASED NEUTRAL SURFACTANT [patent_app_type] => utility [patent_app_number] => 19/443682 [patent_app_country] => US [patent_app_date] => 2026-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11475 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19443682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20598943 [patent_doc_number] => 20260076946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-19 [patent_title] => VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO [patent_app_type] => utility [patent_app_number] => 19/396729 [patent_app_country] => US [patent_app_date] => 2025-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19396729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20598942 [patent_doc_number] => 20260076945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-19 [patent_title] => VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO [patent_app_type] => utility [patent_app_number] => 19/396502 [patent_app_country] => US [patent_app_date] => 2025-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19396502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20567048 [patent_doc_number] => 20260060966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-05 [patent_title] => METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE [patent_app_type] => utility [patent_app_number] => 19/385125 [patent_app_country] => US [patent_app_date] => 2025-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 145150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19385125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20865409 [patent_doc_number] => 12692287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-28 [patent_title] => Polymorphic form of reduced B-nicotinamide mononucleotide calcium salt, and preparation method and use therefor [patent_app_type] => utility [patent_app_number] => 19/263022 [patent_app_country] => US [patent_app_date] => 2025-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 3721 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19263022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20320058 [patent_doc_number] => 20250332146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO [patent_app_type] => utility [patent_app_number] => 19/261756 [patent_app_country] => US [patent_app_date] => 2025-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19261756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19862270 [patent_doc_number] => 20250101056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => SWEETENER COMPOUNDS, sweetened compositionS, and methods of sweetening food products, beverages and the like [patent_app_type] => utility [patent_app_number] => 18/891681 [patent_app_country] => US [patent_app_date] => 2024-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2189 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18891681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19717390 [patent_doc_number] => 12202913 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-21 [patent_title] => Beta-glucan-rich lentinula edodes polysaccharide and preparation method thereof [patent_app_type] => utility [patent_app_number] => 18/813024 [patent_app_country] => US [patent_app_date] => 2024-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3389 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18813024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19826282 [patent_doc_number] => 12247047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-11 [patent_title] => Arnatar compounds and methods for enhanced cellular uptake [patent_app_type] => utility [patent_app_number] => 18/792393 [patent_app_country] => US [patent_app_date] => 2024-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19150 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18792393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554855 [patent_doc_number] => 20240366647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO [patent_app_type] => utility [patent_app_number] => 18/777501 [patent_app_country] => US [patent_app_date] => 2024-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66125 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554853 [patent_doc_number] => 20240366645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO [patent_app_type] => utility [patent_app_number] => 18/777473 [patent_app_country] => US [patent_app_date] => 2024-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554854 [patent_doc_number] => 20240366646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO [patent_app_type] => utility [patent_app_number] => 18/777489 [patent_app_country] => US [patent_app_date] => 2024-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19510517 [patent_doc_number] => 20240342203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER [patent_app_type] => utility [patent_app_number] => 18/750831 [patent_app_country] => US [patent_app_date] => 2024-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18750831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19461581 [patent_doc_number] => 20240315250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => Biofilm Penetrating Compositions and Methods [patent_app_type] => utility [patent_app_number] => 18/734194 [patent_app_country] => US [patent_app_date] => 2024-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14142 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18734194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19550165 [patent_doc_number] => 12133857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-05 [patent_title] => Method for prolonging half-life of theanine in vivo [patent_app_type] => utility [patent_app_number] => 18/676985 [patent_app_country] => US [patent_app_date] => 2024-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 8882 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18676985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19448988 [patent_doc_number] => 20240309118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => METHODS OF MODIFYING CELLULOSE CRYSTALLINITY [patent_app_type] => utility [patent_app_number] => 18/673752 [patent_app_country] => US [patent_app_date] => 2024-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18673752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19809551 [patent_doc_number] => 12240922 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-03-04 [patent_title] => Transition metal complex assisted green hydrolysis for nanocellulose extraction [patent_app_type] => utility [patent_app_number] => 18/672453 [patent_app_country] => US [patent_app_date] => 2024-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5405 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18672453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19389391 [patent_doc_number] => 20240279261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => METHODS FOR PREPARING HIGH-PURITY ARABINOSE CRYSTALS [patent_app_type] => utility [patent_app_number] => 18/651633 [patent_app_country] => US [patent_app_date] => 2024-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 531 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18651633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462414 [patent_doc_number] => 20240316083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 18/632745 [patent_app_country] => US [patent_app_date] => 2024-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18632745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359279 [patent_doc_number] => 20240261313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => KIT FOR PREVENTING OR TREATING FILOVIRUS AND FLAVIVIRUS DISEASES [patent_app_type] => utility [patent_app_number] => 18/614126 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10959 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18614126 [rel_patent_id] =>[rel_patent_doc_number] =>)